Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction.

Archiv der Pharmazie·2026

Same author

Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer.

BioMed research international·2026

Same author

Correction to "Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA".

Analytical chemistry·2026

Same author

Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview.

MedComm·2026

Same author

Seminal Fluid Biomarkers for Early Cancer Detection: A Systematic Review.

Biomedicines·2026

Same author

Thigmotactic navigation and functional enrichment of boar sperm in microfluidic channels.

Reproduction (Cambridge, England)·2026

Search research articles

Related Experiment Video

Updated: Sep 7, 2025

Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms

Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms

Published on: May 31, 2024

Recent advances in lung-on-a-chip models.

Isabella Francis¹, Jesus Shrestha², Keshav Raj Paudel³

¹School of Mechanical Engineering, University of Technology Sydney, Sydney, New South Wales 2007, Australia.

Drug Discovery Today

|June 20, 2022

Summary

This summary is machine-generated.

Advanced lung-on-a-chip models offer a more accurate way to study respiratory diseases and test new drugs. These 3D platforms better mimic the human lung, improving research outcomes.

Keywords:

Lung-on-a-chip Lungs Organ-on-a-chip Respiratory diseases Respiratory system

More Related Videos

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

Construction of a Human Aorta Smooth Muscle Cell Organ-On-A-Chip Model for Recapitulating Biomechanical Strain in the Aortic Wall

Construction of a Human Aorta Smooth Muscle Cell Organ-On-A-Chip Model for Recapitulating Biomechanical Strain in the Aortic Wall

Published on: July 6, 2022

Related Experiment Videos

Last Updated: Sep 7, 2025

Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms

Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms

Published on: May 31, 2024

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

Construction of a Human Aorta Smooth Muscle Cell Organ-On-A-Chip Model for Recapitulating Biomechanical Strain in the Aortic Wall

Construction of a Human Aorta Smooth Muscle Cell Organ-On-A-Chip Model for Recapitulating Biomechanical Strain in the Aortic Wall

Published on: July 6, 2022

Area of Science:

Biomedical Engineering
Respiratory Medicine
Drug Discovery

Background:

Traditional 2D cell cultures and animal models fail to accurately replicate in vivo lung conditions.
The global burden of respiratory diseases necessitates improved methods for therapeutic identification.
Understanding lung pathology and physiology requires more sophisticated research models.

Purpose of the Study:

To review the evolution of lung models from 2D to advanced 3D and lung-on-a-chip platforms.
To discuss the implementation and challenges associated with lung-on-a-chip technology.
To highlight the potential of these advanced models in respiratory disease research and drug development.

Main Methods:

Review of current literature on 2D, 3D, and lung-on-a-chip models.
Analysis of the advantages of lung-on-a-chip platforms in simulating lung microenvironment and function.
Discussion of recent advances and implementation strategies for lung-on-a-chip systems.

Main Results:

Lung-on-a-chip models provide a more accurate simulation of the in vivo lung microenvironment compared to traditional models.
These advanced platforms enhance the precision of drug safety and effectiveness assessments.
Significant progress has been made in lung-on-a-chip technology, despite facing implementation challenges.

Conclusions:

Lung-on-a-chip technology represents a significant advancement over 2D and 3D cell cultures for respiratory research.
These models offer improved accuracy for studying lung diseases and evaluating potential therapeutics.
The platform holds substantial promise for accelerating respiratory disease research and drug discovery pipelines.